today announced two-year outcomes from the double-blind randomized placebo-controlled Phase 3 CardiAMP-HF study of its CardiAMP autologous minimally invasive cell therapy for the treatment of ...

MSCs are a particularly attractive cell type for cardiac therapeutic development because of their ready availability and potential use ... multifaceted mechanism of action requires a cellular ...

A cutting-edge method developed at the University of Michigan Center for Arrhythmia Research successfully uses stem cells to create heart cells capable of mimicking the heart's crucial squeezing ...

The result is abnormal sodium currents that predispose to dangerous cardiac rhythms ... open and ions to rush into heart cells -- this starts the action potential that causes the heart muscle ...